What happens when crop protection products have the potential for side effects on the environment? That’s a job for Tilghman Hall. She gets to the roots of how and why these interactions take place.
She might be the only woman who is happy about mold on a flower bouquet: Marie-Pascale Latorse researches antifungal molecules to find new plant protection solutions.
Want to know how molecules behave? Dr. Michael Beck uses mathematical equations and computers to unravel molecular structures.
Since its establishment in 2014, the Bayer Innovation Center Japan (ICJ) aims to help identifying potential research cooperation projects in Japan that can contribute towards an understanding of disease mechanisms in areas of considerable unmet medical need.
His daily business is dealing with dietary risks: Frank Laporte evaluates the residue of plant protection products in crops and makes sure that they remain at safe levels for consumers.
When a keyword search is not enough: Dr. Wolfgang Thielemann helps scientists find scientific treasures in patent databases. To achieve this, he teaches computers clever ways to handle language.
Scientists test thousands of substances in their hunt for new medicines. Chemist Michael Haerter developed software that analyzes these large-scale experiments. Today, this software plays a key role in the hunt for new active agents.
With her work, she helps many women: Dr. Andrea Wagenfeld oversees gynecological medication in clinical trials. She knows how to measure the success of a treatment.
Pharmacologist and physiologist Dr. Peter Sandner examines one of the most important biochemical processes in the human body, to develop new therapies: the signal transduction cascade NO/cGMP.
Tracking substances on their way through the body: Dr. Christian Zurth has spent his whole career in pharmacokinetics. He knows exactly where active ingredients are effective and how they get there.
Passion and patience are ‘must-have’ skills of every drug discovery team, but sometimes you might even need some luck to discover a substance that can make it through the clinical phases.
Dr. Oliver Politz is working on new drug candidates in oncology research at Bayer: When they show good results, they will be ready to be tested in patients.
A serious long term commitment for bees and crop protection: Dr. Christian Maus speaks up for both at the Bayer Bee Care Center – and addresses many different audiences – sometimes resulting in challenging discussions.
His work is like dancing on a razor’s edge: Dr. Jean-Pierre Vors is a mediator between the worlds of science and management, chemistry and biology, research and the public.
I’m especially proud that I led industry and regulatory collaboration in the field of human exposure assessment for agricultural product. For our kind of research, you need enormous amounts of data, so we all benefit if we work together.
Is the pesticide safe? Is it labelled correctly? I’m mediating all of these questions between inventors and legal authorities.
Fluorine can influence molecules like no other element, and gives me many options to modulate the polarity and solubility of a product.
From research to farming to food production: Ray Shillito has been involved with many aspects of agriculture. He skillfully communicates with various interest groups.
Making life easier for farmers is important. It means a lot to me that I’m contributing to this cause by reliably evaluating crop protectants for safety.
Research must be iterative: At Bayer’s research labs, Dr. Johannes Jansen experiences the dynamic process of endurance, coincidence and discovery.
Russell Jones analyzes the behavior of chemicals in soil and water and helps to develop procedures to ensure their environmental safety.
When I went off to college, I remember thinking, ‘I will never be on a farm again.’ But farming gets into your blood.
Only a few active agents reach the late-stage clinical phase. Dr. Bernard Haendler is accompanying a substance addressing prostate cancer in this stage and further investigating its molecular mode of action.
As we go into the future, we’ll need every aspect of modern agriculture to feed the world. The more we can produce on a small amount of land, the better.
Research, exploration and ping-pong in the lab: Bayer researcher Dr. Lars Baerfacker discovers substances to treat diseases. To do this, he needs resilience, and more:
Even after 30 years of research, Peter Jeschke still finds inspiration in nature. He is making use of natural substance for new pesticides.
Bayer scientist Dr. Catherine Feuillet proves that scientific persistence leads to success: After eleven years of collaborative research worldwide, she contributed to decoding the bread wheat genome. Here, she explains what mindset is needed to help scientists achieve their research goals and fulfill their purpose.
With a talent for tinkering, this skilled trained metalworker made his way up the ladder to become the Head of Packaging and Technology Innovation.
The amount of farmland remains the same – or is even decreasing–, but a growing number of people need to be fed. This is what Jeroen Van Rie is working on.
Some 6,000 participants, innovations from approximately 250 international startups, more than 200 companies and prominent guests from around the world recently met up at the CUBE Tech Fair in Berlin.
In the 1990s, Bernard Pélissier was part of a team of pioneers: They were the first in Europe to create an herbicide-resistant plant
How do insect pests develop resistance to crop protection agents? Dr. Ralf Nauen is on the hunt for answers.
Failures are a normal part of medical research. As a leading cardiovascular researcher, Dr. Alexander Straub keeps going.
How can we boost yields in wheat plants? Dr. Claus Frohberg from Bayer in Ghent, Belgium, is looking for answers.
The range of available, effective cancer drugs is still very limited. As a result, biochemist Anette Sommer searches for compounds to use in new medicines.
Four startups, four exciting digital health ideas, and a raving kick-off party: the “Grants4Apps Accelerator” 2016 is on! Now it’s 100 days of making their businesses fit for the market.
Singapore offers the perfect environment to advance science and innovation in human health. This makes it an essential node in Bayer’s global network of science and innovation hubs.
Five Bayer science and innovation hubs worldwide form close ties with local scientific networks, academic partners, biotech startups, and pharma companies. The CoLaborator Berlin is one of them.
Researchers from the German Cancer Research Center and Bayer collaborate on innovative immunotherapy strategies and aim to harness the immune system to fight tumors.